{"id":45284,"date":"2025-10-30T16:51:29","date_gmt":"2025-10-30T08:51:29","guid":{"rendered":"https:\/\/flcube.com\/?p=45284"},"modified":"2025-10-30T16:51:29","modified_gmt":"2025-10-30T08:51:29","slug":"eli-lilly-and-nvidia-forge-record%e2%80%91breaking-ai%e2%80%91powered-supercomputer-for-pharma","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=45284","title":{"rendered":"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma"},"content":{"rendered":"\n<p><strong>Eli Lilly &amp; Co.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/LLY:NYSE\">NYSE: LLY<\/a>) today announced a groundbreaking partnership with <strong>NVIDIA<\/strong> to build the most powerful supercomputer ever owned and operated by a pharmaceutical company. The new machine, a world\u2011first NVIDIA DGX\u202fSuperPOD featuring the DGX\u202fB300 system, will power an \u201c<strong>AI Factory<\/strong>\u201d\u2014a dedicated computing infrastructure designed to manage the entire artificial intelligence lifecycle, from data ingestion and model training to parameter fine\u2011tuning and large\u2011scale inference.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-why-this-matters\"><strong>Why This Matters<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Unprecedented Scale<\/strong> \u2013 The DGX\u202fB300 platform delivers petaflops of GPU\u2011accelerated compute, enabling rapid autonomous learning and iterative improvement across millions of molecular simulations.<\/li>\n\n\n\n<li><strong>End\u2011to\u2011End AI Workflow<\/strong> \u2013 The AI Factory will streamline data pipelines, model development, and deployment, dramatically shortening the time from discovery to clinical candidate.<\/li>\n\n\n\n<li><strong>Cross\u2011Functional Impact<\/strong> \u2013 Beyond drug discovery, the platform will accelerate manufacturing optimization, medical imaging analytics, and enterprise\u2011level AI agents across Eli\u202fLilly\u2019s global operations.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\"><strong>Strategic Implications<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Drug Discovery Acceleration<\/strong> \u2013 AI\u2011driven screening will identify, optimize, and validate novel molecules at a pace previously unattainable in pharma.<\/li>\n\n\n\n<li><strong>Manufacturing Efficiency<\/strong> \u2013 Predictive models will reduce batch failures and improve yield, cutting costs and time to market.<\/li>\n\n\n\n<li><strong>Healthcare AI Deployment<\/strong> \u2013 The infrastructure will support advanced diagnostics and personalized treatment algorithms, reinforcing Eli\u202fLilly\u2019s commitment to data\u2011driven therapeutics.<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This release contains forward\u2011looking statements that involve risks and uncertainties. Actual results may differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly &amp; Co. (NYSE: LLY) today announced a groundbreaking partnership with NVIDIA to build&#8230;<\/p>\n","protected":false},"author":1,"featured_media":45285,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[99,199,911],"class_list":["post-45284","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-ai","tag-eli-lilly","tag-nyse-lly"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Eli Lilly &amp; Co. (NYSE: LLY) today announced a groundbreaking partnership with NVIDIA to build the most powerful supercomputer ever owned and operated by a pharmaceutical company. The new machine, a world\u2011first NVIDIA DGX\u202fSuperPOD featuring the DGX\u202fB300 system, will power an \u201cAI Factory\u201d\u2014a dedicated computing infrastructure designed to manage the entire artificial intelligence lifecycle, from data ingestion and model training to parameter fine\u2011tuning and large\u2011scale inference.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=45284\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma\" \/>\n<meta property=\"og:description\" content=\"Eli Lilly &amp; Co. (NYSE: LLY) today announced a groundbreaking partnership with NVIDIA to build the most powerful supercomputer ever owned and operated by a pharmaceutical company. The new machine, a world\u2011first NVIDIA DGX\u202fSuperPOD featuring the DGX\u202fB300 system, will power an \u201cAI Factory\u201d\u2014a dedicated computing infrastructure designed to manage the entire artificial intelligence lifecycle, from data ingestion and model training to parameter fine\u2011tuning and large\u2011scale inference.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=45284\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-30T08:51:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45284#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45284\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma\",\"datePublished\":\"2025-10-30T08:51:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45284\"},\"wordCount\":246,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45284#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3007.webp\",\"keywords\":[\"AI\",\"Eli Lilly\",\"NYSE: LLY\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45284#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45284\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=45284\",\"name\":\"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45284#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45284#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3007.webp\",\"datePublished\":\"2025-10-30T08:51:29+00:00\",\"description\":\"Eli Lilly & Co. (NYSE: LLY) today announced a groundbreaking partnership with NVIDIA to build the most powerful supercomputer ever owned and operated by a pharmaceutical company. The new machine, a world\u2011first NVIDIA DGX\u202fSuperPOD featuring the DGX\u202fB300 system, will power an \u201cAI Factory\u201d\u2014a dedicated computing infrastructure designed to manage the entire artificial intelligence lifecycle, from data ingestion and model training to parameter fine\u2011tuning and large\u2011scale inference.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45284#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=45284\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45284#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3007.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/3007.webp\",\"width\":1080,\"height\":608,\"caption\":\"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=45284#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma - Insight, China&#039;s Pharmaceutical Industry","description":"Eli Lilly & Co. (NYSE: LLY) today announced a groundbreaking partnership with NVIDIA to build the most powerful supercomputer ever owned and operated by a pharmaceutical company. The new machine, a world\u2011first NVIDIA DGX\u202fSuperPOD featuring the DGX\u202fB300 system, will power an \u201cAI Factory\u201d\u2014a dedicated computing infrastructure designed to manage the entire artificial intelligence lifecycle, from data ingestion and model training to parameter fine\u2011tuning and large\u2011scale inference.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=45284","og_locale":"en_US","og_type":"article","og_title":"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma","og_description":"Eli Lilly & Co. (NYSE: LLY) today announced a groundbreaking partnership with NVIDIA to build the most powerful supercomputer ever owned and operated by a pharmaceutical company. The new machine, a world\u2011first NVIDIA DGX\u202fSuperPOD featuring the DGX\u202fB300 system, will power an \u201cAI Factory\u201d\u2014a dedicated computing infrastructure designed to manage the entire artificial intelligence lifecycle, from data ingestion and model training to parameter fine\u2011tuning and large\u2011scale inference.","og_url":"https:\/\/flcube.com\/?p=45284","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-30T08:51:29+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=45284#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=45284"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma","datePublished":"2025-10-30T08:51:29+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=45284"},"wordCount":246,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=45284#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007.webp","keywords":["AI","Eli Lilly","NYSE: LLY"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=45284#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=45284","url":"https:\/\/flcube.com\/?p=45284","name":"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=45284#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=45284#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007.webp","datePublished":"2025-10-30T08:51:29+00:00","description":"Eli Lilly & Co. (NYSE: LLY) today announced a groundbreaking partnership with NVIDIA to build the most powerful supercomputer ever owned and operated by a pharmaceutical company. The new machine, a world\u2011first NVIDIA DGX\u202fSuperPOD featuring the DGX\u202fB300 system, will power an \u201cAI Factory\u201d\u2014a dedicated computing infrastructure designed to manage the entire artificial intelligence lifecycle, from data ingestion and model training to parameter fine\u2011tuning and large\u2011scale inference.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=45284#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=45284"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=45284#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007.webp","width":1080,"height":608,"caption":"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=45284#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Eli\u202fLilly and NVIDIA Forge Record\u2011Breaking AI\u2011Powered Supercomputer for Pharma"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/3007.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45284","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45284"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45284\/revisions"}],"predecessor-version":[{"id":45286,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/45284\/revisions\/45286"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/45285"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45284"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45284"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45284"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}